Former Vice President, ECOM Consultants, Inc., an investo

1

• Overview of Investor Relations Capabilities

2
Rx COMMUNICATIONS

• Specialists in the life science and healthcare
  industries
• Partner-driven -- Senior level counsel on EVERY
  account
• Partners have been through up and down market
  cycles, various political healthcare agendas and
  technology trends

3
Rx COMMUNICATIONS

• Experience with private and public companies
  domestic and international
• Focused on what we do best Investor Relations
  and Financial Media Relations
• Strong Wall Street and media contacts
• Headquartered in New York City

4
PRIVATE COMPANIES

• Services for Private Companies

5
WHY EMBARK ON AN IR/PR PROGRAM AS A PRIVATE
COMPANY?

• Lay the groundwork for future financings and
  eventual IPO
• Assist with partnering activities by building
  corporate awareness
• Build awareness of disease indications to
  generate product interest
• Align company with reputable bankers
• Become accustomed to working within disclosure
  rules i.e. Reg FD

6
PROVIDING VALUE TO PRIVATE COMPANIES

• Develop key messages positioned for analysts and
  investors
• Develop collateral materials to tell story
  integrating key messages
• Target and facilitate introductions to venture
  capitalists and institutional investors
• Target and advise on corporate finance team
• Target and facilitate introductions to sell-side
  analysts

7
PROVIDING VALUE TO PRIVATE COMPANIES

• Build presence on the web
• Develop story ideas for the media
• Cultivate reporter interest
• Introduce to conference circuit
• Properly position company news
• Develop company disclosure policy

8
ACTIVITIES SUROUNDING IPO

• Assist in the selection of banking team
  beginning of quiet period
• Press release announcing registration for
  offering
• Develop roadshow presentation
• Supplement bankers list of target institutions
• Presentation training

9
ACTIVITIES SURROUNDING IPO

• Teach-ins at banks
• Roadshow
• Press release announcing completion of IPO
• Welcome letter to new shareholders
• Create disclosure policy
• Quiet period lasts for 25 days following the
  close of IPO

10
PUBLIC COMPANIES

• Services for Public Companies

11
AFTER-MARKET SUPPORT

• Need for continual dialogue with shareholders
• On-going targeting of investors for future
  financings
• Increase analyst coverage beyond banking support
• Fulfill disclosure requirements
• Crisis communications
• Strategic media out-reach

12
GETTING STARTED FIRST STEPS

• Strategy session in order to immerse ourselves in
  corporate story
• Define key message points
• Understand perceptions existent in the
  marketplace
• Create targeted list of sell-side analysts,
  venture capitalists and fund managers

13
GETTING STARTED FIRST STEPS

• Review collateral materials
• Create VIP blast e-mail/fax lists
• Develop media lists
• Design action plan

14
Rx COMMUNICATIONS CAPABILITIES

• Strategic Counsel
• Roadshows
• Analyst Contact
• Investor Targeting
• Investment and Industry Conferences
• Follow-up and Analysis to Key Events
• Press Release Writing
• News Conferences/Press Briefings
• Video/Radio News Releases
• Fact Sheets
• Annual Reports

15
Rx COMMUNICATIONS CAPABILITIES

• Crisis Communications
• Mergers and Acquisitions
• Positioning Strategy
• Perception Audits
• Conference Calls
• Presentation Training
• Placement Strategy
• Financial, Trade and Local Media Contacts
• Slide Presentations
• Web Site Development

16
THE Rx TEAM

• Melody A. Carey, Co-President
• Founded Rx in 2000
• Head of Corporate Communications and
  Spokesperson, Schein Pharmaceutical, Inc.
• Director of Investor Relations,
• The Multicare Companies, Inc.
• Executive, Noonan/Russo Communications
• Former healthcare/life sciences investment
  banker, Kidder, Peabody Co.

17
THE Rx TEAM

• Rhonda Chiger, Co-President
• Founded Rx in 2000
• Senior Managing Director, Global Consulting
  Practice, Thomson Financial
• Managed Life Sciences departments for
  Noonan/Russo and Dewe Rogerson
• Established London office for healthcare investor
  relations firm
• Former Manager, Investor Relations, American
  Stock Exchange

18
The Rx Team

• Eric Goldman, Vice President
• 25 years experience in public relations and as a
  media relations strategist specializing in
  biotechnology, healthcare, technology and
  consumer products
• Senior Director and Vice President at
  GlobalFluency
• Handled media relations at Spector Associates
  and Brouillard Communications, a division of J.
  Walter Thompson
• Earned 2 Silver Anvil awards for public relations
  excellence

19
THE Rx TEAM

• Paula B. Schwartz, Senior Vice President
• Former Partner, FRB/Weber Shandwick, oldest and
  largest Investor Relations firm in the U.S.
• Former Vice President, ECOM Consultants, Inc., an
  investor relations firm
• Former Vice President/Director of Investor
  Relations Programs, KCSA Public Relations, a
  public relations and investor relations
  consultancy

20
Rx COMMUNICATIONS CURRENT CLIENT LIST

• Alexandria Real Estate Equities, Inc. (NYSE ARE)
• Alexion Pharmaceuticals Inc. (Nasdaq ALXN)
• Bio-Path Holdings, Inc. (OTCBB BPTH)
• Catalyst Pharmaceutical Partners, Inc. (Nasdaq
  CPRX)
• Complix (Private)
• CureFAKtor Pharmaceuticals (Private)
• Glycotex, Inc. (Private)
• Intact Medical Corporation (Private)
• MAXIMUS, Inc. (NYSE MMS)

21
Rx COMMUNICATIONS CURRENT CLIENT LIST

• MolMed S.p.A. (Milan MLM)
• Neovacs, SA (Alternext Paris ALNEV)
• Omthera Pharmaceuticals, Inc. (Private)
• PDI, Inc. (Nasdaq PDII)
• TetraLogic Pharmaceuticals (Private)
• Theratechnologies (TSX TH)
• ThromboGenics NV (Euronext Brussels THR)
• ZIOPHARM Oncology, Inc. (Nasdaq ZIOP)

22
OURx SUCCESSES

• Helped to grow Alexion Pharmaceuticals
  institutional shareholder base from 30 in 1996
  to approximately 95 today.
• Launched not-for-profit Immune Tolerance
  Institute resulting in broad coverage in the U.S.
  including CBS Radio Network, San Francisco
  Business Times and Drug Discovery News
• Garnered coverage for Catalyst Pharmaceutical
  Partners compound for cocaine addiction.
  Placements included cover stories in Newsweek,
  Scientific American Mind and NeuroInvestment

23
OURx SUCCESSES

• Designed and implemented IR program for American
  CareSource Holdings which led the company to be
  ranked as the number one stock performer on The
  NASDAQ Capital Market for 2008.
• An aggressive investor outreach campaign on
  behalf of Genaissance Pharmaceuticals allowed
  Genaissance to regain compliance with Nasdaqs 1
  listing rule requirement.
• Guided Kos Pharmaceuticals through a failed
  marketing alliance which caused over two million
  shares to trade (four times the average daily
  trading volume) and the stock never dropped below
  2.

24
OURx SUCCESSES

• Arranged feature coverage focused on Hodgkins and
  non-Hodgkins lymphoma for MethylGene with Genetic
  Engineering News, Pink Sheet, BioCentury and
  Pharmawire
• Guided ABIOMED on issues management surrounding
  FDA panel meeting. Put FDAs request for
  additional data into perspective with reporters
  and investors. CNBC interview key part of
  strategy.
• Implemented aggressive IR program for
  PharmAthene, Inc. which enabled the company to
  obtain coverage from two new sell-side analysts,
  garner investments from four new institutional
  funds and increase trading volume by three-fold
  within nine months.

25
OURx SUCCESSES
Rx Communications was named Best Small PR
Agency by League of American Communications
Professionals
We are pleased to announce that Rx Communications
has been selected by PR Week as a finalist
for Boutique PR Agency of the Year
Rx Communications Group was honored with the 2008
Stevie Award for Best Investor Relations Program
for work on behalf of specialty pharmaceutical
company, NexMed, Inc.
26
OURx SUCCESSES
We are also pleased to share that our work for
ImpactRx has won an Honorable Mention Award in
LACPs (League of American Communications
Professionals) 2002 Publicity Campaign
Competition.
Rx Communications was honored with the 2002
SABRE Awards Certificate of Excellence for
Building a North American Investor Base for
client Syngenta AG.
Rx Communications received an honorable
Mention Award from PR News, as part of the PR
News Platinum PR Awards 2003. The award was
issued in the Financial/Investor Relations
category, for the company's work on behalf of
Genaissance Pharmaceuticals, Inc.
27
WHY Rx COMMUNICATIONS?

• Specialist industry knowledge and expertise
• Personal attention from Rx partners
• Decades of experience in strategic counsel and
  implementation of financial public relations
  programs
• Unique niche in working with private companies
• Well versed in IPOs, secondary offerings, PIPEs,
  venture rounds and mergers and acquisitions
• The Street knows and trusts us

28

• For Additional Information
• Rx Communications Group, LLC
• 445 Park Avenue
• 10th Floor
• New York, NY 10022
• [phone]
• www.RxIR.com